Combined Antithrombotic Treatment With Aspirin and Clopidogrel for Patients With Capsular Warning Syndrome A Case Report

dc.contributor.authorAsil, Talip
dc.contributor.authorIr, Nasif
dc.contributor.authorKaraduman, Fatih
dc.contributor.authorCagli, Bekir
dc.contributor.authorTuncel, Sedat
dc.date.accessioned2024-06-12T10:55:41Z
dc.date.available2024-06-12T10:55:41Z
dc.date.issued2012
dc.departmentTrakya Üniversitesien_US
dc.description.abstractCapsular warning syndrome is characterized by recurrent transient ischemic attacks and is caused by microthrombosis or hypoperfusion of small-sized vessels. The pathophysiological basis of this syndrome is not well understood and currently a consensus has not been reached on its optimal treatment. In this study, we present 2 cases with favorable clinical outcomes after combined antithrombotic treatment with loading doses of clopidogrel and aspirin.en_US
dc.identifier.doi10.1097/NRL.0b013e318247b9a5
dc.identifier.endpage69en_US
dc.identifier.issn1074-7931
dc.identifier.issue2en_US
dc.identifier.pmid22367831en_US
dc.identifier.scopus2-s2.0-84858110611en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage68en_US
dc.identifier.urihttps://doi.org/10.1097/NRL.0b013e318247b9a5
dc.identifier.urihttps://hdl.handle.net/20.500.14551/19502
dc.identifier.volume18en_US
dc.identifier.wosWOS:000300908200003en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofNeurologisten_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCapsular Warning Syndromeen_US
dc.subjectAntithromboticsen_US
dc.subjectClopidogrelen_US
dc.titleCombined Antithrombotic Treatment With Aspirin and Clopidogrel for Patients With Capsular Warning Syndrome A Case Reporten_US
dc.typeArticleen_US

Dosyalar